Stay updated on Nivolumab Combinations in EGFR+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combinations in EGFR+ NSCLC Clinical Trial page.

Latest updates to the Nivolumab Combinations in EGFR+ NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNew Revision: v3.4.2 was added and the funding-status notice (and Revision: v3.4.1) was removed, reflecting routine site maintenance. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check20 days agoChange DetectedAdded a site-wide funding notice and updated the site revision from v3.4.0 to v3.4.1. No study record data or core content were changed.SummaryDifference0.4%

- Check28 days agoChange DetectedGlossary toggle is now visible and changes are color-coded (green for additions, red for deletions) with the revision updated to v3.4.0; the 'No FEAR Act data' note and the older revision (v3.3.4) were removed.SummaryDifference0.5%

- Check42 days agoChange DetectedRevision tag in the page footer updated from v3.3.3 to v3.3.4; no changes to study data or visible page content.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2; these are maintenance changes in the page footer and do not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page now shows Revision: v3.3.2 and removed Revision: v3.2.0.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Combinations in EGFR+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in EGFR+ NSCLC Clinical Trial page.